Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015 (2015), Article ID 483208, 6 pages
http://dx.doi.org/10.1155/2015/483208
Clinical Study

Radiation-Associated Toxicities in Obese Women with Endometrial Cancer: More Than Just BMI?

1Department of Radiation Oncology, City of Hope, Duarte, CA 91010, USA
2Department of Radiation Oncology, University of Southern California, Los Angeles, CA 90033, USA
3Department of Gynecologic Oncology, Obstetrics-Gynecology, University of Southern California, Los Angeles, CA 90033, USA
4Genentech-Roche, 1 DNA Way, MS 444B, South San Francisco, CA 94080, USA

Received 31 December 2014; Revised 29 April 2015; Accepted 12 May 2015

Academic Editor: Thomas Efferth

Copyright © 2015 Savita V. Dandapani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2013,” CA: Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Kong, N. Johnson, H. C. Kitchener, and T. A. Lawrie, “Adjuvant radiotherapy for stage I endometrial cancer,” Cochrane Database of Systematic Reviews, vol. 3, Article ID CD003916, 2012. View at Google Scholar · View at Scopus
  3. J. D. Wright, N. I. B. Medel, J. Sehouli, K. Fujiwara, and T. J. Herzog, “Contemporary management of endometrial cancer,” The Lancet, vol. 379, no. 9823, pp. 1352–1360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. V. E. Von Gruenigen, C. Tian, H. Frasure, S. Waggoner, H. Keys, and R. R. Barakat, “Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group Study,” Cancer, vol. 107, no. 12, pp. 2786–2791, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Nout, V. Smit, H. Putter et al., “Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial,” The Lancet, vol. 375, no. 9717, pp. 816–823, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. C. L. Creutzberg, R. A. Nout, M. L. M. Lybeert et al., “Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 4, pp. e631–e638, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. H. M. Keys, J. A. Roberts, V. L. Brunetto et al., “A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study,” Gynecologic Oncology, vol. 92, no. 3, pp. 744–751, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. A. Secord, L. J. Havrilesky, D. M. O'Malley et al., “A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer,” Gynecologic Oncology, vol. 114, no. 3, pp. 442–447, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Anderson, J. P. Connor, J. I. Andrews et al., “Obesity and prognosis in endometrial cancer,” The American Journal of Obstetrics & Gynecology, vol. 174, no. 4, pp. 1171–1179, 1996. View at Google Scholar
  10. E. J. Crosbie, C. Roberts, W. Qian, A. M. Swart, H. C. Kitchener, and A. G. Renehan, “Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial,” European Journal of Cancer, vol. 48, no. 6, pp. 853–864, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. S. L. Park, M. T. Goodman, Z.-F. Zhang, L. N. Kolonel, B. E. Henderson, and V. W. Setiawan, “Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort,” International Journal of Cancer, vol. 126, no. 2, pp. 490–499, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. V. W. Setiawan, H. P. Yang, M. C. Pike et al., “Type I and II endometrial cancers: have they different risk factors?” Journal of Clinical Oncology, vol. 31, no. 20, pp. 2607–2618, 2013. View at Publisher · View at Google Scholar
  13. http://www.rtog.org/ResearchAssociates/AdverseEventReporting/AcuteRadiationMorbidityScoringCriteria.aspx.
  14. P. M. Webb, Obesity and Gynecologic Cancer Etiology and Survival, American Society of Clinical Oncology educational book, 2013. View at Publisher · View at Google Scholar
  15. B. A. Jereczek-Fossa, J. Jassem, and A. Badzio, “Relationship between acute and late normal tissue injury after postoperative radiotherapy in endometrial cancer,” International Journal of Radiation Oncology, Biology, Physics, vol. 52, no. 2, pp. 476–482, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. L. L. Lin, L. Hertan, R. Rengan, and B.-K. K. Teo, “Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance,” International Journal of Radiation Oncology Biology Physics, vol. 83, no. 2, pp. 670–675, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Yavas, C. Yavas, H. Acar et al., “Dosimetric comparison of 3-dimensional conformal and field-in-field radiotherapy techniques for the adjuvant treatment of early stage endometrial cancer,” Physica Medica, vol. 29, no. 6, pp. 577–582, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Yavas, C. Yavas, O. S. Kerimoglu, and C. Celik, “The impact of body mass index on radiotherapy technique in patients with early-stage endometrial cancer: a single-center dosimetric study,” International Journal of Gynecological Cancer, vol. 24, no. 9, pp. 1607–1615, 2014. View at Publisher · View at Google Scholar
  19. N. Fournier-Bidoz, Y. M. Kirova, F. Campana, R. Dendale, and A. Fourquet, “Simplified field-in-field technique for a large-scale implementation in breast radiation treatment,” Medical Dosimetry, vol. 37, no. 2, pp. 131–137, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. E. M. Ko, M. J. Funk, L. H. Clark, and W. R. Brewster, “Did GOG99 and PORTEC1 change clinical practice in the United States?” Gynecologic Oncology, vol. 129, no. 1, pp. 12–17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Martra, C. Kunos, H. Gibbons et al., “Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study,” American Journal of Obstetrics & Gynecology, vol. 198, no. 1, pp. 89.e1–89.e8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Everett, H. Tamimi, B. Greer et al., “The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer,” Gynecologic Oncology, vol. 90, no. 1, pp. 150–157, 2003. View at Publisher · View at Google Scholar · View at Scopus